Stewart Appelrouth, Director at HEMISPHERX BIOPHARMA INC (HEB), bought 9,677 shares at $4.03 ($39K) on 2019-06-21, disclosed to the SEC on 2019-06-25.
Open-market purchase of $39k HEB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| AIM | BUY | 2024-03-18 | $30K | — | Filing → |
| AIM | BUY | 2023-01-04 | $25K | — | Filing → |
| AIM | BUY | 2021-02-25 | $25K | — | Filing → |